Raymond James Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Raymond James Financial's RPRX Position: Q3 2026 in Review
Raymond James Financial increased its Royalty Pharma (RPRX) stake by 0.53% in Q3 2026, buying an estimated $500K and bringing the position to 1,608,354 shares worth $93.9M. The position accounts for 0.03% of the portfolio, ranked #586.
Raymond James Financial first reported a position in RPRX in Q4 2024 and has held it in 8 quarters since. 701 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Raymond James Financial held 1,608,354 shares of Royalty Pharma worth $93.9M as of Q3 2026.
- Raymond James Financial bought 8,473 Royalty Pharma shares in Q3 2026, an estimated $500K.
- Royalty Pharma made up 0.03% of Raymond James Financial's portfolio in Q3 2026, its #586 holding.
- Raymond James Financial first reported a position in Royalty Pharma in Q4 2024 and has held it in 8 quarters since.
- 701 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.